Sanofi Offers Dice Billions to Replace Injections With Pills
- Companies to work on 12 possible drug targets over five years
- Sanofi to pay over $50 million at first, take stake in Dice
This article is for subscribers only.
Sanofi may pay Dice Molecules as much as $2.3 billion as France’s largest drugmaker looks to make pills work in place of injections for some diseases.
Sanofi agreed to pay Dice more than $50 million initially to get exclusive access to some of its technology and take an equity stake in the closely held company, which uses smaller chemicals to mimic the effect of drugs that require injections or infusions, according to a statement Wednesday. The companies will work on 12 potential drug targets over five years. Dice stands to get as much as $184 million for each candidate if it meets certain development goals, such as key clinical milestones or a regulatory submission.